Medpace Holdings, Inc. Quarterly Debt-to-equity in % from Q2 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Medpace Holdings, Inc. quarterly Debt-to-equity history and growth rate from Q2 2017 to Q3 2024.
  • Medpace Holdings, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 159 %, a 37.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 159 -94.3 -37.2% Sep 30, 2024
Q2 2024 178 -93.6 -34.4% Jun 30, 2024
Q1 2024 203 -91.2 -31% Mar 31, 2024
Q4 2023 236 +7.54 +3.3% Dec 31, 2023
Q3 2023 254 +95.8 +60.7% Sep 30, 2023
Q2 2023 272 +157 +136% Jun 30, 2023
Q1 2023 295 +212 +255% Mar 31, 2023
Q4 2022 229 +156 +214% Dec 31, 2022
Q3 2022 158 +85.3 +118% Sep 30, 2022
Q2 2022 115 +45.8 +65.8% Jun 30, 2022
Q1 2022 82.9 +15.1 +22.3% Mar 31, 2022
Q4 2021 72.9 +7.61 +11.7% Dec 31, 2021
Q3 2021 72.5 +11.1 +18.1% Sep 30, 2021
Q2 2021 69.5 +10.3 +17.5% Jun 30, 2021
Q1 2021 67.8 +11.4 +20.2% Mar 31, 2021
Q4 2020 65.3 +8.19 +14.3% Dec 31, 2020
Q3 2020 61.4 +2.95 +5.05% Sep 30, 2020
Q2 2020 59.2 -2.62 -4.24% Jun 30, 2020
Q1 2020 56.4 -11.4 -16.9% Mar 31, 2020
Q4 2019 57.1 -17.1 -23% Dec 31, 2019
Q3 2019 58.4 -22.1 -27.4% Sep 30, 2019
Q2 2019 61.8 -19.7 -24.2% Jun 30, 2019
Q1 2019 67.8 -8.03 -10.6% Mar 31, 2019
Q4 2018 74.2 +6.57 +9.72% Dec 31, 2018
Q3 2018 80.5 +19.1 +31% Sep 30, 2018
Q2 2018 81.5 +22.9 +39.1% Jun 30, 2018
Q1 2018 75.9 Mar 31, 2018
Q4 2017 67.6 Dec 31, 2017
Q3 2017 61.5 Sep 30, 2017
Q2 2017 58.6 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.